Exenatide can inhibit calcification of human VSMCs through the NF-kappaB/RANKL signaling pathway

Retrospective cohort study evaluating exenatide twice daily and long-acting insulin analogs in a Veterans Health Administration population with type 2 diabetes

(2014) M. Bounthavong et al.   DIABETES & METABOLISM

Adiponectin attenuates the osteoblastic differentiation of vascular smooth muscle cells through the AMPK/mTOR pathway

(2014) Jun-Kun Zhan et al.   EXPERIMENTAL CELL RESEARCH

Comparison of the effects on glycaemic control and β-cell function in newly diagnosed type 2 diabetes patients of treatment with exenatide, insulin or pioglitazone: a multicentre randomized parallel-group trial (the CONFIDENCE study)

(2014) W. Xu et al.   JOURNAL OF INTERNAL MEDICINE

Increased Calcification in Osteoprotegerin-Deficient Smooth Muscle Cells: Dependence on Receptor Activator of NF-κB Ligand and Interleukin 6

(2014) Andrea Callegari et al.   JOURNAL OF VASCULAR RESEARCH

Dynamic risk factors associated with non-severe hypoglycemia in patients treated with insulin glargine or exenatide once weekly 与每日一次使用甘精胰岛素或者每周一次使用艾塞那肽治疗的患者出现非严重低血糖相关的动态危险因素

(2014) Sanjoy K. Paul et al.   Journal of Diabetes

Cross-Talk of Receptor Activator of Nuclear Factor-κB Ligand Signaling With Renin–Angiotensin System in Vascular Calcification

(2013) Mariana Kiomy Osako et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Oxidized low density lipoprotein enhanced RANKL expression in human osteoblast-like cells. Involvement of ERK, NFkappaB and NFAT

(2013) Cécile Mazière et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

The Mammalian Target of Rapamycin Signalling Pathway Is Involved in Osteoblastic Differentiation of Vascular Smooth Muscle Cells

(2013) Jun-Kun Zhan et al.   CANADIAN JOURNAL OF CARDIOLOGY

Treatment of patients with type 2 diabetes with exenatide once weekly versus oral glucose-lowering medications or insulin glargine: achievement of glycemic and cardiovascular goals

(2013) Alison R Meloni et al.   Cardiovascular Diabetology

Association of serum osteoprotegerin with vascular calcification in patients with type 2 diabetes

(2013) Atsushi Aoki et al.   Cardiovascular Diabetology

Novel fusion of GLP-1 with a domain antibody to serum albumin prolongs protection against myocardial ischemia/reperfusion injury in the rat

(2013) Weike Bao et al.   Cardiovascular Diabetology

Vascular calcification

(2013) Ziad A. Massy et al.   CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION

Anti-diabetic actions of glucagon-like peptide-1 on pancreatic beta-cells

(2013) Young-Sun Lee et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Improving major amputation rates in the multicomplex diabetic foot patient: focus on the severity of peripheral arterial disease

(2013) Andrej Brechow et al.   Therapeutic Advances in Endocrinology and Metabolism

Effects of Exenatide vs. Metformin on endothelial function in obese patients with pre-diabetes: a randomized trial

(2012) Aaron S Kelly et al.   Cardiovascular Diabetology

The RANKL/RANK/OPG Signaling Pathway Mediates Medial Arterial Calcification in Diabetic Charcot Neuroarthropathy

(2011) A. Ndip et al.   DIABETES

Beyond glucose lowering: Glucagon-like peptide-1 receptor agonists, body weight and the cardiovascular system

(2011) B. Vergès et al.   DIABETES & METABOLISM

Metformin stimulates osteoprotegerin and reduces RANKL expression in osteoblasts and ovariectomized rats

(2011) Qi-Guang Mai et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Combined effects of ascorbic acid and phosphate on rat VSMC osteoblastic differentiation

(2011) P. Ciceri et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Apelin Attenuates the Osteoblastic Differentiation of Vascular Smooth Muscle Cells

(2011) Peng-Fei Shan et al.   PLoS One

RANKL Is a Downstream Mediator for Insulin-Induced Osteoblastic Differentiation of Vascular Smooth Muscle Cells

(2011) Ling-Qing Yuan et al.   PLoS One

Association of tumor necrosis factor-related apoptosis-inducing ligand with total and cardiovascular mortality in older adults

(2010) Stefano Volpato et al.   ATHEROSCLEROSIS

Inhibition of Monocyte Adhesion to Endothelial Cells and Attenuation of Atherosclerotic Lesion by a Glucagon-like Peptide-1 Receptor Agonist, Exendin-4

(2010) M. Arakawa et al.   DIABETES

Selenium suppressed hydrogen peroxide-induced vascular smooth muscle cells calcification through inhibiting oxidative stress and ERK activation

(2010) Hongmei Liu et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies

(2010) The Emerging Risk Factors Collaboration   LANCET

Connective tissue growth factor is a downstream mediator for preptin-induced proliferation and differentiation in human osteoblasts

(2009) You-Shuo Liu et al.   AMINO ACIDS

RANKL Increases Vascular Smooth Muscle Cell Calcification Through a RANK-BMP4–Dependent Pathway

(2009) Sara Panizo et al.   CIRCULATION RESEARCH

Exenatide Reduces Infarct Size and Improves Cardiac Function in a Porcine Model of Ischemia and Reperfusion Injury

(2009) Leo Timmers et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Exenatide as a treatment for diabetes and obesity: Implications for cardiovascular risk reduction

(2008) Derek D. Mafong et al.   Current Atherosclerosis Reports